Monday, June 29, 2020

Gilead Prices COVID-19 Drug At $2,340 Per Patient In Developed Nations

Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the...

from NDTV News - Latest https://ift.tt/3dKZIH5
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Iranian Crude Loading Resumes At Kharg Island After US Blockade Lifted

Three very large crude carriers, each capable of hauling about 2 million barrels of crude, are moored at the Sea Island terminal to the west...